argenx SE
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
01 jun 2015 - 07:09
Statutaire naam
argenx SE
Titel
arGEN-X to present at Jefferies 2015 Global Healthcare Conference on Tuesday, 2 June at 8:00 am EDT
Bericht
Breda, the Netherlands / Ghent, Belgium, 1 June 2015 - arGEN-X N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced that Chief Executive Officer, Tim Van Hauwermeiren, will present a corporate update at the Jefferies 2015 Global Healthcare Conference in New York City (NY, USA) on Tuesday, 2 June 2015 at 8:00 am EDT.
Gerelateerde downloads
Datum laatste update: 28 juli 2024